Newsfeeds Archive - Page 37 of 167

1 minute read

Versus Systems Prices 2.1M Unit Offering For Gross Proceeds Of ~$2.1M

December 7, 8:35 AM

LOS ANGELES, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Versus Systems Inc. ("Versus" or the "Company") (NASDAQ:VS) today announced the pricing of its public offering of 2,100,000 units for gross proceeds of

1 minute read

AVROBIO Announces Clinical Data For Gaucher Disease Gene Therapy; Says ‘Following positive feedback from FDA and MHRA, registrational, global Phase 2/3 clinical trial for GD3 planned for second half 2023’

By Bill Haddad

December 7, 8:33 AM

New compelling clinical data from first-ever Gaucher disease type 3 (GD3) patient and four Gaucher disease type 1 (GD1) patients dosed with investigational AVR-RD-02 Data from first pediatric GD3 patient, the more

AVRO

1 minute read

Alico Says ‘the Company and its independent public accounting firm determined they need additional time to complete the audit of such financial results.’

By Bill Haddad

December 7, 8:24 AM

Alico, Inc. ("Alico" or the "Company") (NASDAQ:ALCO) announced on December 6, 2022 that although the Company had planned to be able to report its financial results for the period ended September 30,

ALCO

1 minute read

United Natural Foods Q1 EPS $1.13 Misses $1.15 Estimate, Sales $7.53B Beat $7.48B Estimate

By Bill Haddad

December 7, 8:08 AM

United Natural Foods (NYSE:UNFI) reported quarterly earnings of $1.13 per share which missed the analyst consensus estimate of $1.15 by 1.74 percent. This is a 16.49 percent increase over earnings of $0.97 per share from

UNFI

1 minute read

Lovesac Says ‘we are planning for continued inflationary pressure on consumers and intend to maintain tight expense management and careful prioritization of critical spending to support continued growth.’

By Bill Haddad

December 7, 8:06 AM

Mr. Nelson continued, "We believe we are well positioned for the all-important fourth quarter holiday-season where early signs point to strong cash flow generation for the quarter. At the same time, we are

LOVE

1 minute read

Prometheus Biosciences Announces Results For PRA023 In Both ARTEMIS-UC Phase 2 And APOLLO-CD Phase 2a Studies; ARTEMIS-UC Met Primary Endpoint

By Bill Haddad

December 7, 8:02 AM

SAN DIEGO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (NASDAQ:RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and

RXDX

2 minute read

Replimune Enters Clinical Collaboration Agreement With Roche For Development Of RP3 In Colorectal Cancer And Hepatocellular Carcinoma

By Bill Haddad

December 7, 7:36 AM

P3 will be developed in combination with atezolizumab and bevacizumab for the third-line treatment of colorectal cancer (CRC) and for the first- and second-line treatment of hepatocellular carcinoma

REPL

1 minute read

Lowe’s Affirms 2022 Outlook, Sees FY22 Total Sales $97B-$98B., Sees Adj. EPS $13.65-$13.80

By Bill Haddad

December 7, 7:02 AM

Full Year 2022 Outlook -- a 53-week year (comparisons to full year 2021 –a 52-week year) Total sales of approximately $97 to $98 billion, including the 53rd week 53rd week expected to

LOW

1 minute read

AP Projects Sen. Warnock Victory In GA Runoff Election

By Bill Haddad

December 6, 11:34 PM

https://apnews.com/article/2022-midterm-elections-walker-warnock-runoff-3d4e4d1ab1760792454e1cbd618ce332

SPY

1 minute read

News

Doma Holdings To Reduce 40% Of Workforce, Expects $9M-$10M In Employment Related Charges And Estimates Annualized Compensation Expense Savings Of $85M-$90M

By Bill Haddad

December 6, 1:03 PM

On December 6, 2022, Doma Holdings, Inc. (the “Company”) committed to implementing a strategic initiative and corresponding reduction in workforce (the "Reduction Plan"), designed to reduce costs,On December 6, 2022, Doma Holdings, Inc.

DOMA